A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus
Conditions:   Systemic Lupus Erythematosus;   Lupus Erythematosus Intervention:   Drug: Imvotamab Sponsor:   IGM Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Descartes-08 for Patients With Systemic Lupus Erythematosus
Condition:   Systemic Lupus Erythematosus (SLE) Intervention:   Drug: Descartes-08 Sponsor:   Cartesian Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials